Published in Am J Med Genet A on March 01, 2007
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab (2013) 1.74
Growth and associations between auxology, caregiving environment, and cognition in socially deprived Romanian children randomized to foster vs ongoing institutional care. Arch Pediatr Adolesc Med (2010) 1.16
Prader-Willi syndrome and autism spectrum disorders: an evolving story. J Neurodev Disord (2011) 1.05
Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest (2015) 1.04
Gender of pediatric recombinant human growth hormone recipients in the United States and globally. J Clin Endocrinol Metab (2008) 0.93
Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J Endocrinol (2011) 0.92
Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol (2013) 0.90
Prader-Willi syndrome: A primer for clinicians. Int J Pediatr Endocrinol (2011) 0.87
Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol (2016) 0.86
Clinical management of behavioral characteristics of Prader-Willi syndrome. Neuropsychiatr Dis Treat (2010) 0.84
Growth standards of infants with Prader-Willi syndrome. Pediatrics (2011) 0.84
Growth patterns and the use of growth hormone in the mucopolysaccharidoses. J Pediatr Rehabil Med (2010) 0.83
Effects of growth hormone treatment in adults with Prader-Willi syndrome. Growth Horm IGF Res (2013) 0.82
IV. Growth Failure in Institutionalized Children. Monogr Soc Res Child Dev (2011) 0.81
Prader-Willi syndrome and growth hormone deficiency. J Clin Res Pediatr Endocrinol (2014) 0.80
Early clinical indicators of developmental outcome in abusive head trauma. Childs Nerv Syst (2012) 0.79
Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment. Korean J Pediatr (2012) 0.79
Systematic review of the clinical and genetic aspects of Prader-Willi syndrome. Korean J Pediatr (2011) 0.78
French database of children and adolescents with Prader-Willi syndrome. BMC Med Genet (2008) 0.77
Prader-Willi syndrome: a single center's experience in Korea. Korean J Pediatr (2014) 0.77
Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study. J Clin Sleep Med (2009) 0.77
Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome. J Child Psychol Psychiatry (2016) 0.75
Inclusion of chiropractic care in multidisciplinary management of a child with Prader-Willi syndrome: a case report. J Chiropr Med (2009) 0.75
Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art. Ital J Pediatr (2017) 0.75
Prader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive Medicine. Diseases (2016) 0.75
Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med (2006) 6.10
Improvement of fitness, body composition, and insulin sensitivity in overweight children in a school-based exercise program: a randomized, controlled study. Arch Pediatr Adolesc Med (2005) 2.96
Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr (2004) 1.91
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab (2013) 1.74
Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) (2008) 1.67
Impact of enhanced sensory input on treadmill step frequency: infants born with myelomeningocele. Pediatr Phys Ther (2011) 1.55
Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls. J Pediatr (2005) 1.54
School-based fitness changes are lost during the summer vacation. Arch Pediatr Adolesc Med (2007) 1.51
Muscle activation patterns in infants with myelomeningocele stepping on a treadmill. Pediatr Phys Ther (2013) 1.41
Sex-related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol (2006) 1.39
Environment and obesity in the National Children's Study. Environ Health Perspect (2008) 1.34
Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab (2002) 1.22
Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab (2010) 1.11
Fitness is a stronger predictor of fasting insulin levels than fatness in overweight male middle-school children. J Pediatr (2007) 1.10
Home food availability, parental dietary intake, and familial eating habits influence the diet quality of urban Hispanic children. Child Obes (2014) 1.08
Stepping responses of infants with myelomeningocele when supported on a motorized treadmill. Phys Ther (2008) 1.02
Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids. Ann Allergy Asthma Immunol (2007) 1.00
Standardized childhood fitness percentiles derived from school-based testing. J Pediatr (2012) 0.98
A comprehensive team approach to the management of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab (2004) 0.98
Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol (2009) 0.96
Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. J Clin Endocrinol Metab (2008) 0.94
Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr (2003) 0.90
Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol (2011) 0.90
Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol (2005) 0.88
School-based exercise improves fitness, body composition, insulin sensitivity, and markers of inflammation in non-obese children. J Pediatr Endocrinol Metab (2009) 0.88
Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol (2015) 0.88
Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr (2010) 0.87
Submaximal treadmill test predicts VO2max in overweight children. J Pediatr (2009) 0.86
Reliable prediction of insulin resistance by a school-based fitness test in middle-school children. Int J Pediatr Endocrinol (2009) 0.84
Growth standards of infants with Prader-Willi syndrome. Pediatrics (2011) 0.84
Off the growth curve: the challenge of childhood obesity. WMJ (2005) 0.84
TODAY--a stark glimpse of tomorrow. N Engl J Med (2012) 0.84
Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls. Obesity (Silver Spring) (2013) 0.82
Fitness level and body composition are associated with inflammation in non-obese children. J Pediatr Endocrinol Metab (2009) 0.81
Growth hormone therapy for Prader-Willi syndrome: a critical appraisal. J Pediatr Endocrinol Metab (2004) 0.81
Childhood obesity and medical neglect. Pediatrics (2009) 0.81
Objectively assessed physical activity and sedentary behaviour does not differ between children and adolescents with and without a congenital heart defect: a pilot examination. Cardiol Young (2011) 0.80
Inhaled corticosteroids, growth, and compliance. N Engl J Med (2002) 0.80
Growth hormone post-marketing surveillance: safety, sales, and the unfinished task ahead. J Clin Endocrinol Metab (2010) 0.79
Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis. Int J Pediatr Endocrinol (2010) 0.78
Gender and race influence metabolic benefits of fitness in children: a cross-sectional study. Int J Pediatr Endocrinol (2012) 0.78
Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. Curr Opin Pediatr (2013) 0.78
DXA provides a valid minimum weight in wrestlers. Med Sci Sports Exerc (2007) 0.78
Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers. Clin Pediatr (Phila) (2007) 0.78
Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome. Horm Res Paediatr (2016) 0.77
Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr (2016) 0.77
In Nonobese Girls, Waist Circumference as a Predictor of Insulin Resistance Is Comparable to MRI Fat Measures and Superior to BMI. Horm Res Paediatr (2015) 0.77
Prader-Willi syndrome and growth hormone therapy: take a deep breath and weigh the data. J Pediatr (2012) 0.77
Weight perceptions of parents with children at risk for diabetes. BMC Res Notes (2012) 0.76
Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol (2002) 0.75
Additional sensitivity data for newborn screening for congenital adrenal hyperplasia in Wisconsin. J Pediatr (2006) 0.75
Poor glycemic control predicts occurrence and progression of microalbuminuria in children with type I diabetes. J Pediatr (2008) 0.75
Respiratory Depression in Young Prader Willi Syndrome Patients following Clonidine Provocation for Growth Hormone Secretion Testing. Int J Pediatr Endocrinol (2010) 0.75
Identifying children at risk for type 2 diabetes in underserved communities. Diabetes Educ (2011) 0.75
Measuring aerobic cycling power as an assessment of childhood fitness. J Strength Cond Res (2008) 0.75
The influence of fitness on insulin resistance in obese children. Rev Endocr Metab Disord (2009) 0.75
Topical fluticasone propionate lotion does not cause HPA axis suppression. J Pediatr (2006) 0.75
Growth Promotion Ethics and the Challenge to Resist Cosmetic Endocrinology . Horm Res Paediatr (2017) 0.75
Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty. Sports Health (2011) 0.75
Measuring aerobic cycling power as an assessment of childhood fitness. J Strength Cond Res (2007) 0.75
Disparities in Fitness and Physical Activity Among Children. WMJ (2017) 0.75
Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence. Curr Opin Pediatr (2017) 0.75
Treating short stature with growth hormone. Virtual Mentor (2005) 0.75
In Nonobese Children, Fitness and BMI are Independent Predictors of Fasting Insulin. Pediatr Exerc Sci (2015) 0.75